Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board
The appointment further strengthens the company's scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria's approach for developing novel therapies for neurodegenerative and neuropsych…